PMID- 31195248 OWN - NLM STAT- MEDLINE DCOM- 20190729 LR - 20190729 IS - 1872-6283 (Electronic) IS - 0379-0738 (Linking) VI - 301 DP - 2019 Aug TI - Post-mortem diagnosis of kidney impairment: An experimental study. PG - 271-277 LID - S0379-0738(18)30946-0 [pii] LID - 10.1016/j.forsciint.2019.05.034 [doi] AB - The determination of the role that drugs may have played in a death is an important part of the investigation into unexplained deaths. Renal impairment may lead to a reduction in drug excretion rate and therefore an accumulation of drugs or metabolites, leading to possible toxic or lethal effects. Creatinine levels are known to be stable in the post mortem period and in life can give an indication of kidney function. There are however widely reported limitations when using creatinine in isolation and so we investigated the usefulness of using estimated glomerular filtration rate (eGFR) for scoring an individual as having renal impairment using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) formula. We analysed unpreserved vitreous for creatinine in 812 individuals using an isotope dilution mass spectrometry (ID-MS) traceable enzymatic. We found that the biochemical analysis of post mortem vitreous creatinine and subsequent calculation of eGFR is a useful adjunct to the standard testing that takes place during a post-mortem examination and can assist in death investigation. Using an eGFR of <60 mL/min/1.73 m(2) gave a sensitivity of 94.3% and specificity of 97.3% when scoring an individual as having renal impairment. We therefore recommend the calculation of eGFR for the determination of possible renal impairment in post mortem investigations. It is, of course, always pertinent to interpret any results using a wealth of case information. Extreme caution should be exercised in cases where insufficient clinical information/history is available, particularly in cases in which there is suspected diabetic ketoacidosis, dehydration or hospitalisation prior to death. CI - Copyright (c) 2019 Elsevier B.V. All rights reserved. FAU - Maskell, Peter D AU - Maskell PD AD - School of Science, Engineering and Technology, Abertay University, Dundee, DD1 1HG, UK. Electronic address: p.maskell@abertay.ac.uk. FAU - Penney, Elizabeth AU - Penney E AD - School of Applied Sciences, University of Huddersfield, Huddersfield HD1 3DH, UK. FAU - Smith, Paul R AU - Smith PR AD - Forensic Toxicology Service, University Hospitals of Leicester NHS Trust, Leicester, LE1 5WW, UK. FAU - Hikin, Laura J AU - Hikin LJ AD - Forensic Toxicology Service, University Hospitals of Leicester NHS Trust, Leicester, LE1 5WW, UK. FAU - Morley, Stephen R AU - Morley SR AD - Forensic Toxicology Service, University Hospitals of Leicester NHS Trust, Leicester, LE1 5WW, UK. LA - eng PT - Journal Article DEP - 20190524 PL - Ireland TA - Forensic Sci Int JT - Forensic science international JID - 7902034 RN - 0 (Biomarkers) RN - AYI8EX34EU (Creatinine) MH - Adolescent MH - Adult MH - Aged MH - Aged, 80 and over MH - Biomarkers/metabolism MH - Creatinine/*metabolism MH - Female MH - Forensic Toxicology MH - *Glomerular Filtration Rate MH - Humans MH - Male MH - Mass Spectrometry/methods MH - Middle Aged MH - Renal Insufficiency/*diagnosis MH - Sensitivity and Specificity MH - Vitreous Body/*metabolism MH - Young Adult OTO - NOTNLM OT - Creatinine OT - Death investigation OT - Renal impairment OT - eGFR EDAT- 2019/06/14 06:00 MHDA- 2019/07/30 06:00 CRDT- 2019/06/14 06:00 PHST- 2018/10/23 00:00 [received] PHST- 2019/04/04 00:00 [revised] PHST- 2019/05/17 00:00 [accepted] PHST- 2019/06/14 06:00 [pubmed] PHST- 2019/07/30 06:00 [medline] PHST- 2019/06/14 06:00 [entrez] AID - S0379-0738(18)30946-0 [pii] AID - 10.1016/j.forsciint.2019.05.034 [doi] PST - ppublish SO - Forensic Sci Int. 2019 Aug;301:271-277. doi: 10.1016/j.forsciint.2019.05.034. Epub 2019 May 24.